C12N 2840/005
Cell cycle specific
Official title: cell cycle specific
C12N2840/005 (Cell cycle specific) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 5
- Assignees
- 4
- Inventors
- 11
- Latest grant
- 25 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Method of detecting Polycomb Repressive Complex activity25 Jun 2024US 12,018,253 B2Imba—Institut FüR Molekulare Biotechnologie GmbH
- Detection and destruction of cancer cells using programmed genetic vectors4 Oct 2016US 9,458,472 B2Massachusetts Institute of Technology
- Vectors harboring toxic genes, methods and uses therefor3 Nov 2015US 9,175,312 B2Virovek Incorporation
- Immunoengineered pluripotent cells2 Nov 2023US 2023/0348862 A1The Regents of the University of California
- Method of detecting polycomb repressive complex activity26 Mar 2020US 2020/0095575 A1Imba—Institut FüR Molekulare Biotechnologie GmbH
- Immunoengineered pluripotent cells12 Dec 2019US 2019/0376045 A1The Regents of the University of California
- Vectors harboring toxic genes, methods and uses therefor2 Oct 2014US 2014/0296324 A1Virovek Incorporation
- Detection and destruction of cancer cells using programmed genetic vectors29 Sep 2011US 2011/0237652 A1Massachusetts Institute of Technology
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.